Ian Stewart (Partner-Los Angeles) authored the article “Regulatory Compliance More Accessible for Cannabis, Hemp Insurance Market,” published in the February 13, 2024, edition of CLM Magazine. The article acknowledges that marijuana will likely soon be reclassified from Schedule I to Schedule III as a result of the 2023 Department of Health and Human Services recommendation currently under DEA review. Ian notes the reclassification heightens the importance of regulatory compliance to limit risk exposure. “Although there should be a positive long-term impact on cannabis property, commercial liability, product liability, and specialty risk exposures after marijuana is removed from Schedule I, we should expect a tumultuous transition during which those risks may increase.” Ian outlines various potential compliance challenges, including the evolving and often contentious relationship between the hemp and cannabis industries, and provides specific solutions offering “an array of tools germane to the industry…that make compliance monitoring across jurisdictions efficient and easily accessible to the insurance market.”